Atherosclerosis contributes to cognitive dysfunction and Alzheimer's disease-related pathologies. Atherogenic index of plasma (AIP) is a novel and composite biomarker can predict atherosclerosis.
Objective
This study aims to (1) examine the association between the AIP and cognitive performance, and (2) explore the mediating role of oxidative stress biomarkers in this relationship.
Methods
1466 participants over the age of 60 were included from 2011–2014 NHANES. AIP was calculated through log-transformed triglyceride to high-density lipoprotein cholesterol ratios. The assessment of cognition was conducted using the Consortium to Establish a Registry for Alzheimer's Disease (CERAD) test. Weighted linear regression model and restricted cubic spline were carried out to determine the associations between AIP and CERAD scores. The mediation analyses were conducted to assess whether oxidative stress mediates the association.
Results
Higher AIP levels were associated with lower CERAD learning scores. The highest quartile of AIP showed a 0.67-fold decrease (95%CI: −1.30, −0.03; p = 0.041) on the CERAD total score than that in the lowest quartile. Each 1-unit increase in AIP corresponded to reductions in CERAD total and delayed recall scores of approximately 1.09 and 0.54 points, respectively, in the sub-population under 70 years. Moreover, 25(OH)D, an oxidative stress indicator, partially mediated 24% of the association between AIP and the CERAD total score.
Conclusions
AIP has the potential to indicate the risk of cognitive aging, especially that for young-old or female older adults. The supplementation of 25(OH)D may reduce atherosclerosis-related cognitive decline, which could provide some strategies for the prevention of dementia.
GBD. 2019 Dementia forecasting collaborators. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the global burden of disease study 2019. Lancet Public Health2022; 7: e105–e125.
2.
van NieuwkerkACDelewiRWoltersFJ, et al.Cognitive impairment in patients with cardiac disease: implications for clinical practice. Stroke2023; 54: 2181–2191.
3.
YaffeKBahorikALHoangTD, et al.Cardiovascular risk factors and accelerated cognitive decline in midlife: the CARDIA study. Neurology2020; 95: e839–e846.
4.
SabayanBGoudarziRJiY, et al.Intracranial atherosclerosis disease associated with cognitive impairment and dementia: systematic review and meta-analysis. J Am Heart Assoc2023; 12: e032506.
5.
IadecolaC. Revisiting atherosclerosis and dementia. Nat Neurosci2020; 23: 691–692.
6.
SuriMFKZhouJQiaoY, et al.Cognitive impairment and intracranial atherosclerotic stenosis in general population. Neurology2018; 90: e1240–e1247.
7.
WingoAPFanWDuongDM, et al.Shared proteomic effects of cerebral atherosclerosis and Alzheimer's disease on the human brain. Nat Neurosci2020; 23: 696–700.
8.
NezuTHosomiNAokiS, et al.Carotid intima-media thickness for atherosclerosis. J Atheroscler Thromb2016; 23: 18–31.
9.
De Anda-DuranIAlonsoCFLibonDJ, et al.Carotid intima-media thickness and midlife cognitive function: impact of race and social disparities in the Bogalusa heart study. Neurology2022; 98: e1828–e1836.
10.
ZhongWCruickshanksKJSchubertCR, et al.Carotid atherosclerosis and 10-year changes in cognitive function. Atherosclerosis2012; 224: 506–510.
11.
XieBShiXXingY, et al.Association between atherosclerosis and Alzheimer's disease: a systematic review and meta-analysis. Brain Behav2020; 10: e01601.
12.
KhosraviASadeghiMFarsaniES, et al.Atherogenic index of plasma: a valuable novel index to distinguish patients with unstable atherogenic plaques. J Res Med Sci2022; 27: 45.
13.
HuangQLiuZWeiM, et al.The atherogenic index of plasma and carotid atherosclerosis in a community population: a population-based cohort study in China. Cardiovasc Diabetol2023; 22: 125.
14.
XueYJuJZhaoW, et al.Association between atherogenic index of plasma and asymptomatic intracranial arterial stenosis in middle-aged and elderly women: a cross-sectional study in Shandong, China. Nutr Metab Cardiovasc Dis2024; 34: 598–605.
15.
QinMChenB. Association of atherogenic index of plasma with cardiovascular disease mortality and all-cause mortality in the general US adult population: results from NHANES 2005–2018. Cardiovasc Diabetol2024; 23: 255.
16.
TorinoCMattace-RasoFvan SaaseJL, et al.Oxidative stress as estimated by gamma-glutamyl transferase levels amplifies the alkaline phosphatase-dependent risk for mortality in ESKD patients on dialysis. Oxid Med Cell Longev2016; 2016: 8490643.
17.
WuYChengSLeiS, et al.The association between the composite dietary antioxidant index and frailty symptoms: mediating effects of oxidative stress. Clin Interv Aging2024; 19: 163–173.
18.
SongLLiHFuX, et al.Association of the oxidative balance score and cognitive function and the mediating role of oxidative stress: evidence from the national health and nutrition examination survey (NHANES) 2011–2014. J Nutr2023; 153: 1974–1983.
19.
HaarhausMBrandenburgVKalantar-ZadehK, et al.Alkaline phosphatase: a novel treatment target for cardiovascular disease in CKD. Nat Rev Nephrol2017; 13: 429–442.
20.
Vilar-GomezENephewLDVuppalanchiR, et al.High-quality diet, physical activity, and college education are associated with low risk of NAFLD among the US population. Hepatology2022; 75: 1491–1506.
21.
HuangHYangBYuR, et al.Very high high-density lipoprotein cholesterol may be associated with higher risk of cognitive impairment in older adults. Nutr J2024; 23: 79.
22.
YinZXShiXMKrausVB, et al.High normal plasma triglycerides are associated with preserved cognitive function in Chinese oldest-old. Age Ageing2012; 41: 600–606.
23.
GillumRFObisesanTO. High-density lipoprotein cholesterol, cognitive function and mortality in a U.S. National cohort. Lipids Health Dis2011; 10: 26.
24.
HendersonVWGuthrieJRDennersteinL. Serum lipids and memory in a population based cohort of middle age women. J Neurol Neurosurg Psychiatry2003; 74: 1530–1535.
25.
MinQWuZYaoJ, et al.Association between atherogenic index of plasma control level and incident cardiovascular disease in middle-aged and elderly Chinese individuals with abnormal glucose metabolism. Cardiovasc Diabetol2024; 23: 54.
26.
PillaiJABenaJBekrisL, et al.Metabolic syndrome biomarkers relate to rate of cognitive decline in MCI and dementia stages of Alzheimer's disease. Alzheimers Res Ther2023; 15: 54.
27.
RomeroJRBeiserASeshadriS, et al.Carotid artery atherosclerosis, MRI indices of brain ischemia, aging, and cognitive impairment: the Framingham study. Stroke2009; 40: 1590–1596.
28.
GustavssonAMvan WestenDStomrudE, et al.Midlife atherosclerosis and development of Alzheimer or vascular dementia. Ann Neurol2020; 87: 52–62.
29.
RossettiHCWeinerMHynanLS, et al.Subclinical atherosclerosis and subsequent cognitive function. Atherosclerosis2015; 241: 36–41.
30.
KangKMByunMSLeeJH, et al.Association of carotid and intracranial stenosis with Alzheimer's disease biomarkers. Alzheimers Res Ther2020; 12: 106.
31.
ReynoldsCAGatzMPrinceJA, et al.Serum lipid levels and cognitive change in late life. J Am Geriatr Soc2010; 58: 501–509.
32.
AnsteyKJLipnickiDMLowLF. Cholesterol as a risk factor for dementia and cognitive decline: a systematic review of prospective studies with meta-analysis. Am J Geriatr Psychiatry2008; 16: 343–354.
33.
ZhuYLiuXZhuR, et al.Lipid levels and the risk of dementia: a dose-response meta-analysis of prospective cohort studies. Ann Clin Transl Neurol2022; 9: 296–311.
34.
KatsumataYTodorikiHHigashiuesatoY, et al.Very old adults with better memory function have higher low-density lipoprotein cholesterol levels and lower triglyceride to high-density lipoprotein cholesterol ratios: KOCOA project. J Alzheimers Dis2013; 34: 273–279.
35.
LiuCLLinMHPengLN, et al.Late-life metabolic syndrome prevents cognitive decline among older men aged 75 years and over: one-year prospective cohort study. J Nutr Health Aging2013; 17: 523–526.
36.
LuoLYangMHaoQ, et al.Cross-sectional study examining the association between metabolic syndrome and cognitive function among the oldest old. J Am Med Dir Assoc2013; 14: 105–108.
37.
BojarIPinkasJWierzbinska-StepniakA, et al.Cognitive functions, concentration of endogenous estradiol, estrogen receptor alpha (ERalpha) polymorphism in postmenopausal women. Med Sci Monit2016; 22: 3469–3478.
38.
HuangXWenSHuangY, et al.Gender differences in the association between changes in the atherogenic index of plasma and cardiometabolic diseases: a cohort study. Lipids Health Dis2024; 23: 135.
39.
KnoppRHParamsothyPRetzlaffBM, et al.Gender differences in lipoprotein metabolism and dietary response: basis in hormonal differences and implications for cardiovascular disease. Curr Atheroscler Rep2005; 7: 472–479.
40.
DurstineJL. Gender differences in lipids and lipoproteins after cardiac rehabilitation. J Cardiopulm Rehabil2004; 24: 257–258.
41.
YoonHEMoEYShinSJ, et al.Serum gamma-glutamyltransferase is not associated with subclinical atherosclerosis in patients with type 2 diabetes. Cardiovasc Diabetol2016; 15: 108.
42.
OnatACanGOrnekE, et al.Elevated serum uric acid in nondiabetic people mark pro-inflammatory state and HDL dysfunction and independently predicts coronary disease. Clin Rheumatol2013; 32: 1767–1775.
43.
LiuNXuHSunQ, et al.The role of oxidative stress in hyperuricemia and xanthine oxidoreductase (XOR) inhibitors. Oxid Med Cell Longev2021; 2021: 1470380.
44.
SonDHHaHSLeeYJ. Association of serum alkaline phosphatase with the TG/HDL ratio and TyG index in Korean adults. Biomolecules2021; 11: 882.
45.
BaiXQiaoJZhangH. Mildly elevated serum bilirubin and its correlations with lipid levels among male patients undergoing health checkups. Lipids Health Dis2023; 22: 213.
46.
SuQChenHDuS, et al.Association between serum bilirubin, lipid levels, and prevalence of femoral and carotid atherosclerosis: a population-based cross-sectional study. Arterioscler Thromb Vasc Biol2023; 43: 136–145.
47.
WenGYaoLHaoY, et al.Bilirubin ameliorates murine atherosclerosis through inhibiting cholesterol synthesis and reshaping the immune system. J Transl Med2022; 20: 1.
48.
RenkeGStarling-SoaresBBaessoT, et al.Effects of vitamin D on cardiovascular risk and oxidative stress. Nutrients2023; 15: 769.
49.
KhanolkarSHiraniSMishraA, et al.Exploring the role of vitamin D in atherosclerosis and its impact on cardiovascular events: a comprehensive review. Cureus2023; 15: e42470.
50.
WangYSiSLiuJ, et al.The associations of serum lipids with vitamin D status. PLoS One2016; 11: e0165157.
51.
EtgenTSanderDBickelH, et al.Vitamin D deficiency, cognitive impairment and dementia: a systematic review and meta-analysis. Dement Geriatr Cogn Disord2012; 33: 297–305.
52.
MizwickiMTMenegazDZhangJ, et al.Genomic and nongenomic signaling induced by 1alpha,25(OH)2-vitamin D3 promotes the recovery of amyloid-beta phagocytosis by Alzheimer's disease macrophages. J Alzheimers Dis2012; 29: 51–62.
53.
KangJParkMLeeE, et al.The role of vitamin D in Alzheimer's disease: a transcriptional regulator of amyloidopathy and gliopathy. Biomedicines2022; 10: 1824.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
